Becton Dickinson & Co (BDX): Price-to-Projected Revenue Ratio

Stable demand for critical consumables from Becton Dickinson & Co (BDX) guarantees business resilience. Investments in molecular diagnostics and robotic pharmacies drive growth. The expected P/S valuation visualizes market expectations, where the 0.90 mark reflects the latest data. High regulatory barriers and patents make equipment replacement in clinics extremely difficult, cementing the company's dominance.

Becton Dickinson - BDX Market Cap to Future Revenue Ratio (period 07/04/2022 - 11/13/2026)

Analytical breakdowns for Becton Dickinson & Company (BDX)

- stock price and consensus target price:

Stock Quotes Becton Dickinson|BDX - Analyst Consensus Forecast

- stock exchange capitalization data:

Market Value Becton Dickinson & Company|BDX - Real Price to Acquire Entire Company

- book value of equity indicators:

Book Value per Share Becton Dickinson|BDX - Total Stockholders' Equity|Market Value to Book Value Ratio bd.com|BDX - Total Business Assets

- debt level and financial liquidity data:

- financial results and valuation multiples details:

BDX - Net Income|Future Profit Becton Dickinson & Co|BDX - Market Price to Net Income Ratio|Future Price to Earnings Becton, Dickinson and Company|BDX - Price to Earnings Adjusted for Growth Rate|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Becton Dickinson & Company|BDX - Operating profit before amortization|Net earnings per share for the last 12 months Becton Dickinson|BDX - Earnings per share for the trailing year|Quarterly EPS earnings growth bd.com|BDX - Earnings per share growth this year|Earnings growth forecast for next year Becton Dickinson & Co

- revenue and sales details:

BDX - Company Gross Revenue|Projected Sales Volume Becton Dickinson|BDX - Market Cap to Revenue|Price-to-Projected Revenue Ratio Becton Dickinson & Company

Comprehensive company analysis:Becton Dickinson BDX

Manufactured products of Becton Dickinson & Co

To determine the fair value of Becton Dickinson & Co (BDX), utilize the market capitalization to projected revenue ratio, which measures the market's willingness to pay a premium per unit of future sales. By analyzing the projected P/S value, an investor assesses consensus expectations regarding business efficiency and valuation risks. The stability of this multiple confirms the company's dominance in the consumables market, where production scale allows Becton Dickinson & Co (BDX) to maintain premium pricing power.

Who Becton Dickinson & Co competes with

Intuitive - Forward Price-to-Revenue Multiple|Forward P/S Multiple Danaher Corporation DHR|STE - Price-to-Projected Revenue Ratio|West Pharma Corp (WST) - Forward Price-to-Revenue Multiple|BAX: Forward P/S Multiple|Market Cap to Future Revenue Ratio masimo.com (MASI)|Price-to-Projected Revenue Ratio Stevanato Group|Market Cap to Projected Revenue TFX (Teleflex Inc.)|Forward Price-to-Revenue Multiple MMSI (Merit Medical Systems Inc)|Price to Expected Revenue Ratio NVST|Price-to-Projected Revenue Ratio ICU Medical, Inc. ICUI|Market Cap to Expected Sales Ratio dentsplysirona.com (XRAY)|LeMaitre Vascular - Forward P/S Multiple|ATRC: Price-to-Projected Revenue Ratio|STAA: Forward P/S Multiple|Market Cap to Future Revenue Ratio Niagen (NAGE)|ZIMV (ZimVie Inc.) - Forward P/S Multiple|Forward Price-to-Revenue Multiple angiodynamics.com (ANGO)|Forward Price-to-Revenue Multiple CERS (Cerus)|Price to Expected Revenue Ratio TKNO|Price-to-Projected Revenue Ratio Monogram Technologies Inc MGRM|Sharps Technology Inc (STSS) - Market Cap to Future Revenue Ratio|INFU - Price-to-Projected Revenue Ratio|UTMD (utahmed.com) - Market Cap to Projected Revenue|KRMD (korumedical.com) - Forward Price-to-Revenue Multiple|Nyxoah SA - Forward Price to Sales|MBOT (Microbot Medical Inc) - Forward P/S Multiple|Market Cap to Projected Revenue PDEX (Pro-Dex Inc.)|Forward P/S Multiple ZTEK|Market Cap to Expected Sales Ratio elutia.com|Forward P/S Multiple MLSS (Milestone Scientific Inc.)|NXGL - Forward Price-to-Revenue Multiple|RVP - Price-to-Projected Revenue Ratio|HBIO - Forward P/S Multiple|FEMY: Forward P/S Multiple|MHUA - Market Cap to Expected Sales Ratio|Price-to-Projected Revenue Ratio Predictive Oncology Inc|Market Cap to Projected Revenue CJMB (Callan JMB Corp)|Price-to-Projected Revenue Ratio Atrion Corp (ATRI)|Market Cap to Expected Sales Ratio NeuroMetrix Corporation